Evidence Supporting Ervebo Cross-Protection Against Bundibugyo Ebola Prompts Calls for DRC Trials

By Helen Branswell · STAT News · 2026-07-22

Evidence Supporting Ervebo Cross-Protection Against Bundibugyo Ebola Prompts Calls for DRC Trials

STAT News reports that recent human data published in the New England Journal of Medicine suggests Merck’s Ervebo vaccine might defend against the Bundibugyo ebolavirus. While the World Health Organization remains hesitant to deploy the Zaire-specific shot as a primary defense, r

STAT News reports that recent human data published in the New England Journal of Medicine suggests Merck’s Ervebo vaccine might defend against the Bundibugyo ebolavirus. While the World Health Organization remains hesitant to deploy the Zaire-specific shot as a primary defense, r